Related Experiment Video
Updated: Apr 29, 2026
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Hybrid capture II and PapilloCheck® tests for detection of anal high-risk human papillomavirus
Livia Bravo Maia1, Larissa Cardoso Marinho1, Anamélia Lorenzetti Bocca1
1Departamento de Patologia, Hospital Universitário de Brasília, Brasília, DF.
Introduction:
This study evaluated the level of concordance between hybrid capture II (HCII) and PapilloCheck® for the detection of high-risk human papillomavirus (HPV) in anal samples.
Methods:
Anal cell samples collected from 42 human immunodeficiency virus (HIV)+ patients were analyzed.
Results:
Considering only the 13 high-risk HPV types that are detectable by both tests, HCII was positive for 52.3% of the samples, and PapilloCheck® was positive for 52.3%. The level of concordance was 80.9% (Kappa = 0.61).
Conclusions:
Good concordance was observed between the tests for the detection of high-risk HPV.
More Related Videos
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012